Table 1.
Parameters | Patients (n = 57) | Controls (n = 50) | p-value |
---|---|---|---|
Age | 43.56 (±12.3) | 42.08 (±11.28) | 0.517 |
Gender [male] | 29 (50.9%) | 23 (46%) | 0.615 |
Height (cm) | 170.28 (±9.11) | 169.04 (±8.41) | 0.570 |
Weight (kg) | 73.09 (±14.77) | 72.48 (±14.84) | 0.967 |
BMI (kg/m2) | 25.27 (±4.99) | 25.52 (±5.54) | 0.800 |
Stage | |||
Stage I - lymphadenopathy | 19.3% | NA | NA |
Stage II - lymphadenopathy and pulmonary infiltrates |
22.8% | NA | NA |
Stage III - pulmonary infiltrates | 33.3% | NA | NA |
Stage IV - pulmonary fibrosis | 24.6% | NA | NA |
Notes: Data are presented as mean (±std. dev.) or absolute frequency (percentage).
Abbreviation: NA, not applicable.